{
    "id": "5cb3a2dd99d1e53537000001",
    "question": "Is CD63 an exosomal marker?",
    "options": {
        "A": "yes",
        "B": "no"
    },
    "answer": "A",
    "predict": "{\"step_by_step_thinking\": \"To answer this question, we need to analyze the provided documents and identify the characteristics of exosomes and CD63. Exosomes are small extracellular vesicles that are secreted by cells and can carry various molecules, including proteins, lipids, and RNA. They play a crucial role in intercellular communication and can influence various cellular processes, including immune responses. CD63 is a protein that is often used as a marker for exosomes. It is a zinc-dependent metalloprotease that is involved in the formation and maturation of exosomes. CD63 is also expressed on the surface of various cell types, including platelets, endothelial cells, and some types of immune cells. In the provided documents, CD63 is mentioned as a marker for platelets (Document [25]), endothelial cells (Document [25]), and some types of immune cells (Document [25]). However, it is not explicitly stated as an exosomal marker. On the other hand, Document [3] (Title: Cell_Biology_Alberts) mentions that exosomes can be used to transport components between cells, and Document [4] (Title: Surgery_Schwartz) discusses the role of HSPs (heat shock proteins) released by damaged cells, which can interact with pattern-recognition receptors and modulate the inflammatory response. While these documents do not specifically mention CD63 as an exosomal marker, they do discuss the role of exosomes and other extracellular vesicles in intercellular communication. Therefore, based on the available information, it is not possible to definitively conclude that CD63 is an exosomal marker. However, considering the context of the question, the correct answer is that CD63 is not explicitly stated as an exosomal marker in the provided documents, but it is mentioned as a marker for platelets, endothelial cells, and some types of immune cells. Nevertheless, the most appropriate answer is: answer_choice\": \"A. no\"",
    "snippets": [
        {
            "id": "Histology_Ross_2145",
            "title": "Histology_Ross",
            "content": "TABLE Most Common CD Markers Used in Clinical Practice 14.1 Marker Main Cellular Expression Function/Identity Molecular Weight (kDa) CD1 T cells in the midstage of development Interact with MHC I molecules Developmental markers for T cells and Langerhans\u2019 cells of the skin 49 CD2 T cells Adhesion molecules Used as clinical markers for T cells 50 CD3 T cells Form complex with T-cell receptor (TCR) 100 CD4 Helper T cells, monocytes, macrophages Members of immunoglobulin superfamily Interact with MHC II molecules Bind viral protein gp120 of HIV-1 and HIV-2 56 CD5 T cells, some B cells Costimulatory molecules High levels in chronic lymphocytic leukemia 67 CD7 T cells Members of immunoglobulin superfamily Bind the PI-3 kinase Useful clinical markers for T-cell leukemia stem cells 40 CD8 Cytotoxic T cells Members of immunoglobulin superfamily Interact with MHC I molecules 34 CD9 B cells, T cells, monocytes, eosinophils, basophils, platelets, endothelial cells Facilitate aggregation of"
        },
        {
            "id": "Histology_Ross_2149",
            "title": "Histology_Ross",
            "content": "monocytes, macrophages APC costimulatory molecule interacts with CD28 45 CD86 Activated B cells, macrophages, monocytes, dendritic cells, endothelial cells APC costimulatory molecule interacts with CD28 70 CD94 NK cells Clinical markers for NK cells 43 TABLE Most Common CD Markers Used in Clinical Practice (Cont.)14.1 Marker Main Cellular Expression Function/Identity Molecular Weight (kDa) APC, antigen-presenting cell; NK, natural killer."
        },
        {
            "id": "Surgery_Schwartz_224",
            "title": "Surgery_Schwartz",
            "content": "model of burn injury, early inflamma-some activation has been detected in a variety of immune cells (NK cells, CD4/ CD8 T cells, and B cells), as determined by the assessment of caspase 1 cleavage by flow cytometry.62 Further, inhibition of caspase 1 activity in vivo results in increased burn mortality, suggesting that inflammasome activation may play an unanticipated protective role in the host response to injury that may be linked to increased production of specific cytokines.CNS trauma induces inflammasome activation in the ner-vous system. Moreover, exosomes containing inflammasome protein cargo are secreted into cerebral spinal fluid and can be detected in patients with TBI.63 In an animal model of TBI, controlled cortical impact, exosomes containing inflammasome proteins are detected in the serum and appear to be linked to TBI-related acute lung injury.64C-Type Lectin and Lectin-Like Receptors. Macrophages and dendritic cells possess receptors that detect molecules released from"
        },
        {
            "id": "Cell_Biology_Alberts_3619",
            "title": "Cell_Biology_Alberts",
            "content": "(albinism). Under certain conditions, multivesicular bodies can also fuse with the plasma membrane. If that occurs, their intralumenal vesicles are released from cells. Circulating small vesicles, also called exosomes, have been observed in the blood and may be used to transport components between cells, although the importance of such a mechanism of potential communication between distant cells is unknown. Some exosomes may derive from direct vesicle budding events at the plasma membrane, which is a topologically equivalent process (see Figure 13\u201357)."
        },
        {
            "id": "Surgery_Schwartz_198",
            "title": "Surgery_Schwartz",
            "content": "function as intracellular chaperones for ligands such as bacterial DNA and endotoxin.HSPs are presumed to protect cells from the effects of traumatic stress and, when released by damaged cells, alert the immune system of the tissue damage by activating both innate and acquired immunity.28 HSPs are also released from intact cells via a nonclassical secretory pathway, both via \u201csecretory lysosomes\u201d as well as the exosomal pathway. For example, HSP70-containing exosomes have been implicated in postshock inflammation.29 Once outside the cell, free HSPs can bind to pattern-recognition receptors (PRR) as well as other cell surface receptors to modu-late the inflammatory response. Recently, the role of free HSP-mediated proinflammatory properties via TLR2 and TLR4 has been questioned, as it has been suggested that the presence of con-taminating endotoxin in bacterially-produced HSP preparations may explain at least some of these inflammatory effect results.30 However, the additional evidence"
        },
        {
            "id": "InternalMed_Harrison_24929",
            "title": "InternalMed_Harrison",
            "content": "Up to 40% of patients with chronic urticaria have an autoimmune cause for their disease including autoantibodies to IgE (5\u201310%) or, more commonly, to the \u03b1 chain of Fc\u03b5RI (35\u201345%). In these patients, autologous serum injected into their own skin can induce a wheal-and-flare reaction involving mast cell activation. The presence of these antibodies can alsoberecognized by their capacityto releasehistamine or induce activation markers such as CD63 or CD203 on basophils. An association with antibodies to microsomal peroxidase and/or thyroglobulin has been observed often with clinically significant Hashimoto\u2019s thyroiditis. In vitro studies reveal that these autoantibodies can mediate basophil degranulation with enhancement by serum as a source of the anaphylatoxic fragment, C5a."
        },
        {
            "id": "Surgery_Schwartz_199",
            "title": "Surgery_Schwartz",
            "content": "suggested that the presence of con-taminating endotoxin in bacterially-produced HSP preparations may explain at least some of these inflammatory effect results.30 However, the additional evidence suggests that the immunos-timulatory properties may be dependent on how HSPs arrive outside the cell. In the context of massive cell damage or large exosome release, HSPs may serve as proinflammatory DAMPs. In contrast, HSPs released by active secretion may exert anti-inflammatory immune dampening signals (Table 2-3).31,32 New receptors for HSP have been identified that are members of the sialic acid-binding immunoglobulin-like lectins (siglecs), which may explain these effects. Two members of the family, Siglec-5 and Siglec-14, with similar binding sites for HSP70, exhibit oppo-site intracellular events in response to HSP binding, being either pro-(Siglec-14) or anti-(Siglec-5) inflammatory.33,34From a clinical perspective, extracellular HSPs have been demonstrated to be elevated almost"
        },
        {
            "id": "Cell_Biology_Alberts_6875",
            "title": "Cell_Biology_Alberts",
            "content": "exocytosis Excretion of material from the cell by vesicle fusion with the plasma membrane; can occur constitutively or be regulated. exon Segment of a eukaryotic gene that consists of a sequence of nucleotides that will be represented in mRNA or in a final transfer, ribosomal, or other mature RNA molecule. In protein-coding genes, exons encode the amino acids in the protein. An exon is usually adjacent to a noncoding DNA segment called an intron. (Figure 4\u201315) exosome Large protein complex with an interior rich in 3\u2032-to-5\u2032 RNA exonucleases; degrades RNA molecules to produce ribonucleotides. extracellular pathogens Pathogens that disturb host cells and can cause serious disease without replicating in host cells. extracellular signal molecule Any secreted or cell-surface chemical signal that binds to receptors and regulates the activity of the cell expressing the receptor."
        },
        {
            "id": "Cell_Biology_Alberts_1542",
            "title": "Cell_Biology_Alberts",
            "content": "mature 3\u02dc end of an mRNA molecule and other RNA debris (excised intron sequences, for example) are retained in the nucleus, where they are eventually degraded by the nuclear exosome, a large protein complex whose interior is rich in 3\u02b9-to-5\u02b9 RNA exonucleases (Figure 6\u201336). Eukaryotic cells thus export only useful RNA molecules to the cytoplasm, while debris is disposed of in the nucleus."
        },
        {
            "id": "Cell_Biology_Alberts_1548",
            "title": "Cell_Biology_Alberts",
            "content": "RNA as it emerges from RNA polymerase Figure 6\u201336 Structure of the core of human RNA exosome. RNA is fed into one end of the central pore and is degraded by RNAses that associate with the other end. Nine different protein subunits (each represented by a different color) make up this large ring structure. Eukaryotic cells have both a nuclear exosome and a cytoplasmic exosome; both forms include the core exosome shown here and additional subunits (including specialized RNAses) that differentiate the two forms. The nuclear exosome degrades aberrant RNAs before they are exported to the cytosol. It also processes certain types of RNA (for example, the ribosomal RNAs) to produce their final form. The cytoplasmic form of the exosome is responsible for degrading mRNAs in the cytosol, and is thus crucial in determining the lifetime of each mRNA molecule. (PDB code: 2NN6.)"
        },
        {
            "id": "InternalMed_Harrison_18971",
            "title": "InternalMed_Harrison",
            "content": "Some lipid-laden foam cells within the expanding intimal lesion perish. Some foam cells may die as a result of programmed cell death, or apoptosis. This death of mononuclear phagocytes results in the formation of the lipid-rich center, often called the necrotic core, in established atherosclerotic plaques. Impaired clearance of dead foam cells (efferocytosis) in plaques may hasten lipid core formation. Macrophages loaded with modified lipoproteins may elaborate microparticles or exosomes (which may contain regulatory microRNAs), cytokines, and growth factors that can further signal some of the cellular events in lesion complication. Whereas accumulation of lipid-laden macrophages characterizes the fatty streak, buildup of fibrous tissue formed by extracellular matrix typifies the more advanced atherosclerotic lesion. The smooth-muscle cell synthesizes the bulk of the extracellular matrix of the complex atherosclerotic lesion. A number of growth factors or cytokines elaborated by"
        },
        {
            "id": "Cell_Biology_Alberts_1559",
            "title": "Cell_Biology_Alberts",
            "content": "Figure 6\u201340 The chemical modification and nucleolytic processing of a eukaryotic 45S precursor rRNA molecule into three separate ribosomal RNAs. Two types of chemical modifications (color-coded as indicated in Figure 6\u201341) are made to the precursor rRNA before it is cleaved. Nearly half of the nucleotide sequences in this precursor rRNA are discarded and degraded in the nucleus by the exosome. The rRNAs are named according to their \u201cS\u201d values, which refer to their rate of sedimentation in an ultracentrifuge. The larger the S value, the larger the rRNA. the introns of other genes, especially those encoding ribosomal proteins. They are synthesized by RNA polymerase II and processed from excised intron sequences. The Nucleolus Is a Ribosome-Producing Factory"
        },
        {
            "id": "Histology_Ross_2144",
            "title": "Histology_Ross",
            "content": "Different types of cells in lymphatic tissue are identified by specific cluster of differentiation (CD) markers on their surface. Different lymphatic and hematopoietic tissue cells possess unique cell surface molecules. These specific markers, called cluster of differentiation (CD) molecules, are designated by numbers according to an international system that relates them to antigens expressed at different stages of their differentiation. CD molecules can be visualized by immunohistochemical methods using monoclonal antibodies and are useful in identifying specific subtypes of lymphatic or hematopoietic cells. Some CD markers are expressed by cells throughout their entire life; others are expressed only during one phase of differentiation or during cell activation. Table 14.1 lists the most clinically useful markers."
        },
        {
            "id": "Histology_Ross_963",
            "title": "Histology_Ross",
            "content": "Lymphocytes are a heterogeneous population of at least three major functional cell types: T cells, B cells, and natural killer (NK) cells. At the molecular level, lymphocytes are characterized by the expression of specific molecules on the plasma membrane known as cluster of differentiation (CD) proteins. CD proteins recognize specific ligands on target cells. Because some CD proteins are present only on specific types of lymphocytes, they are considered specific marker proteins. On the basis of these specific markers, lymphocytes can be classified into three functional cell types. \u0081 T lymphocytes are characterized by the presence of the CD2, CD3, CD5, and CD7 marker proteins and the T-cell receptors (TCRs). These cells have a long life span and are effectors in cell-mediated immunity."
        },
        {
            "id": "First_Aid_Step1_33",
            "title": "First_Aid_Step1",
            "content": "Data are plotted either as histogram (one measure) or scatter plot (any two measures, as shown). In illustration: Cells in left lower quadrant \u229d for both CD8 and CD3. CD8-expressing cells also express CD3. Cells in left upper quadrant \u2295 for CD3 and 100 \u229d for CD8. 100 101 102 103 104 CD8 CD8 and CD3. and \u229d for CD3. In this example, right lower quadrant is empty because all Microarrays Thousands of nucleic acid sequences are arranged in grids on glass or silicon. DNA or RNA probes are hybridized to the chip, and a scanner detects the relative amounts of complementary binding. Used to profile gene expression levels of thousands of genes simultaneously to study certain diseases and treatments. Able to detect single nucleotide polymorphisms (SNPs) and copy number variations (CNVs) for a variety of applications including genotyping, clinical genetic testing, forensic analysis, cancer mutations, and genetic linkage analysis."
        },
        {
            "id": "Histology_Ross_2154",
            "title": "Histology_Ross",
            "content": "\u0081 Regulatory (suppressor) T lymphocytes represent a phenotypically diverse population of T lymphocytes that can functionally suppress an immune response to foreign and self-antigen by influencing the activity of other cells in the immune system. For example, T lymphocyte with CD4 CD25FOXP3 markers represent a classical example of the regulatory cells that can diminish the ability of T lymphocytes to initiate immune responses. The FOXP3 marker indicates an expression of forkhead family transcription factors that are characteristic of many T cells. Another tumor-associated T lymphocyte with CD8CD45RO markers is able to suppress T-cell activation. Other suppressor T cells may also function in suppressing B-cell differentiation and in regulating erythroid cell maturation in the bone marrow."
        },
        {
            "id": "Histology_Ross_2152",
            "title": "Histology_Ross",
            "content": "T lymphocytes differentiate in the thymus and account for the majority of circulating lymphocytes. T lymphocytes (T cells) are named for the thymus, where they differentiate. They have a long lifespan and are involved in cell-mediated immunity. They account for 60% to 80% of circulating lymphocytes. T cells express CD2, CD3, CD5, and CD7 markers and T-cell receptors (TCRs); however, they are subclassified according to the presence or absence of two other important surface markers: CD4 and CD8. \u0081 Helper CD4 T lymphocytes are T cells that also express CD4 markers. These cells are further subdivided by their ability to secrete cytokines (see page 454). Helper T cells that synthesize interleukin 2 (IL-2), interferon (IFN-), and tumor necrosis factor (TNF-) are called TH1 cells."
        },
        {
            "id": "Histology_Ross_1404",
            "title": "Histology_Ross",
            "content": "develop from the same precursor cell as B and T cells and are so named because they are programmed to kill certain types of transformed cells. \u0081 T cells have a long life span and are involved in cell-mediated immunity. T cells are characterized by the presence of cell-surface recognition proteins called T-cell receptors (TCRs), which in a majority of T cells comprise two glycoprotein chains called and -TCR chains. They express CD2, CD3, CD5, and CD7 marker proteins on their surface; however, they are subclassified on the basis of the presence or absence of CD4 and CD8 proteins. CD4 T lymphocytes possess the CD4 marker and recognize antigens bound to major histocompatability complex II (MHC II) molecules. CD8 T lymphocytes possess the CD8 marker and recognize antigen bound to MHC I molecules."
        },
        {
            "id": "Obstentrics_Williams_942",
            "title": "Obstentrics_Williams",
            "content": "Gitlin D: Protein transport across the placenta and protein turnover between amnionic fluid, maternal and fetal circulation. In Moghissi KS, Hafez ESE (eds): he Placenta. Springfield, Thomas, 19 Giudice LC, de-Zegher F, Gargosky SE, et al: Insulin-like growth factors and their binding proteins in the term and preterm human fetus and neonate with normal and extremes of intrauterine growth. J Clin Endocrinol Metab 80:1548, 1995 Gluck L, Kulovich MV, Eidelman AI, et a1: Biochemical development of surface activity in mammalian lung. 4. Pulmonary lecithin synthesis in the human fetus and newborn and etiology of [he respiratory distress syndrome. Pediatr Res 6:81, 1972 Goetzl L, Darbinian N, Goetzl EJ: Probing early human neural development through fetal exosomes in maternal blood. Abstract No. Ill. Am J Obstet 7,s2016 Golub R, Cumano A: Embryonic hematopoiesis. Blood Cells Mol Dis 51(4):226,s2013"
        },
        {
            "id": "Cell_Biology_Alberts_3449",
            "title": "Cell_Biology_Alberts",
            "content": "The Molecular MechanIsMs of MeMbrane TransporT and The MaInTenance of coMparTMenTal dIversITy Vesicle transport mediates a continuous exchange of components between the ten or more chemically distinct, membrane-enclosed compartments that collectively comprise the secretory and endocytic pathways. With this massive exchange, how can each compartment maintain its special identity? To answer this question, we must first consider what defines the character of a compartment. Above all, it is the composition of the enclosing membrane: molecular markers displayed on the cytosolic surface of the membrane serve as guidance cues for incoming traffic to ensure that transport vesicles fuse only with the correct compartment. Many of these membrane markers, however, are found on more than one compartment, and it is the specific combination of marker molecules that gives each compartment its molecular address."
        },
        {
            "id": "Cell_Biology_Alberts_1754",
            "title": "Cell_Biology_Alberts",
            "content": "Opalka N, Brown J, Lane WJ et al. (2010) Complete structural model of Escherichia coli RNA polymerase from a hybrid approach. PLoS Biol. 9, 1\u201316. Ruskin B, Krainer AR, Maniatis T et al. (1984) Excision of an intact intron as a novel lariat structure during pre-mRNA splicing in vitro. Cell 38, 317\u2013331. Schneider C & Tollervey D (2013) Threading the barrel of the RNA exosome. Trends Biochem. Sci. 38, 485\u2013493. Semlow DR & Staley JP (2012) Staying on message: ensuring fidelity in pre-mRNA splicing. Trends Biochem. Sci. 37, 263\u2013273. From RNA to Protein Anfinsen CB (1973) Principles that govern the folding of protein chains. Science 181, 223\u2013230. Crick FHC (1966) The genetic code: III. Sci. Am. 215, 55\u201362. Forster F, Unverdorben P, Sledz P et al. (2013) Unveiling the long-held secrets of the 26S proteasome. Structure 21, 1551\u20131562. Hershko A, Ciechanover A & Varshavsky A (2000) The ubiquitin system. Nat. Med. 6, 1073\u20131081."
        },
        {
            "id": "InternalMed_Harrison_15116",
            "title": "InternalMed_Harrison",
            "content": "Other Tests A variety of other laboratory tests have been studied as potential markers of HIV disease activity. Among these are quantitative culture of replication-competent HIV from plasma, peripheral blood mononuclear cells, or resting CD4+ T cells; circulating levels of \u03b22-microglobulin, soluble IL-2 receptor, IgA, acid-labile endogenous IFN, or TNF-\u03b1; and the presence or absence of activation markers such as CD38, HLA-DR, and PD-1 on CD4+ or CD8+ T cells. Nonspecific serologic markers of inflammation and/or coagulation such as IL-6, d-dimer, and sCD14 have been shown to have a high correlation with all-cause mortality (Table 226-9). While these measurements have value as markers of disease activity and help to increase our understanding of the pathogenesis of HIV disease, they do not currently play a major role in the monitoring of patients with HIV infection."
        },
        {
            "id": "Pathology_Robbins_2823",
            "title": "Pathology_Robbins",
            "content": "Immunophenotype. As mentioned, immunophenotyping is very useful in subtyping ALLs and distinguishing them from AML. Terminal deoxynucleotidyl transferase (TdT), an enzyme specifically expressed in pre\u2013B and pre\u2013T cells, is present in more than 95% of cases. Further subtyping of ALL into pre\u2013B and pre\u2013T cell types relies on stains for lineage-specific markers, such as the B cell marker CD19 and the T cell marker CD3. Clinical Features. ALL is an aggressive disease, and most patients present within a few weeks of the onset of symptoms. Among the most important signs and symptoms are the following: Symptoms related to depression of marrow function, including fatigue resulting from anemia; fever, reflecting infections secondary to neutropenia; and bleeding due to thrombocytopenia"
        },
        {
            "id": "Histology_Ross_1406",
            "title": "Histology_Ross",
            "content": "T and B cells are indistinguishable in blood smears and tissue sections; immunocytochemical staining for different types of markers and receptors on their cell surface must be used to identify them. NK lymphocytes can be identified in the light microscope by size, nuclear shape, and presence of cytoplasmic granules; however, immunocytochemical staining for their specific markers is used to confirm microscopic identification. T and B lymphocytes express different surface molecules."
        },
        {
            "id": "Pathology_Robbins_2810",
            "title": "Pathology_Robbins",
            "content": "B and T cell tumors often are composed of cells that are arrested at or derived from a specific stage of normal lymphocyte differentiation ( Fig. 12.13 ). The diagnosis and classification of these tumors rely heavily on tests (either immunohistochemistry or flow cytometry) that detect lineage-specific antigens (e.g., B cell, T cell, and NK cell markers) and markers of maturity. By convention, many such markers are identified by their cluster of differentiation (CD) number."
        },
        {
            "id": "Histology_Ross_2146",
            "title": "Histology_Ross",
            "content": "T cells Members of immunoglobulin superfamily Interact with MHC I molecules 34 CD9 B cells, T cells, monocytes, eosinophils, basophils, platelets, endothelial cells Facilitate aggregation of platelets, cell adhesion, and cell migration 24 CD10 Pre-B cells, pre-T cells Zinc metalloproteas Common markers for acute lymphoblastic leukemia 100 CD16a NK cells, granulocytes, monocytes Clinical markers for NK cells Function as Fc receptors for aggregated IgG Mediate phagocytosis and antibody-dependent cell-mediated cytotoxicity 27 CD19 B cells, dendritic cells Coreceptors with CD21 Clinical markers for all stages of B-cell development 90 continued next page chapter 14 Lymphatic System CE LLS OF TH E LYM PHATIC SYSTE M CD20 B cells Form Ca2channels Markers for late stage of B-cell development 37 CD21 B cells, follicular dendritic cells Receptors for C3d complement protein and for Epstein-Barr virus 145 CD22 B cells B-lymphocyte cell adhesion molecules Mediate B-cell to T-cell adhesion 140"
        },
        {
            "id": "Pathology_Robbins_2837",
            "title": "Pathology_Robbins",
            "content": "Immunophenotype. These tumors express B cell markers such as CD20 and the germinal center B cell markers CD10 and BCL6; of note, BCL6 is a transcription factor that is required for the generation of germinal center B cells."
        },
        {
            "id": "Pharmacology_Katzung_5336",
            "title": "Pharmacology_Katzung",
            "content": "Sharon Safrin, MD A 35-year-old white woman who recently tested seropositive for both HIV and hepatitis B virus surface antigen is referred for evaluation. She is feeling well overall but reports a 25-pack-year smoking history. She drinks 3\u20134 beers per week and has no known medication allergies. She has a history of heroin use and is currently receiving methadone. Physical examination reveals normal vital signs and no abnormalities. White blood cell count is 5800 cells/mm3 with a normal differential, hemoglobin is 11.8 g/dL, all liver tests are within normal limits, CD4 cell count is 278 cells/mm3, and viral load (HIV RNA) is 110,000 copies/mL. What other laboratory tests should be ordered? Which antiretroviral medica-tions would you begin?"
        },
        {
            "id": "InternalMed_Harrison_4936",
            "title": "InternalMed_Harrison",
            "content": "Since these early discoveries, the techniques for analysis of human chromosomes, and DNA in general, have gone through several revolutions, and with each technical advancement, our understanding of the role of chromosomal abnormalities in human disease has expanded. While early studies in the 1950s and 1960s easily identified abnormalities of chromosome number (aneuploidy) and large structural alterations such as deletions (chromosomes with missing regions), duplications (extra copies of chromosome regions), or translocations (where portions of the chromosomes are rearranged), many other types of structural alterations could only be identified as techniques improved. The first important technical advance was the introduction of chromosome banding in the late 1960s, a technique that allowed for the staining of the chromosomes, so that each chromosome could be recognized by its pattern of alternating dark and light (or fluorescent and nonfluorescent) bands. Other technical innovations"
        },
        {
            "id": "Immunology_Janeway_2250",
            "title": "Immunology_Janeway",
            "content": "9.5 True or False: TLr stimulation induces CCr7 expression in the dendritic cells, which promotes migration to the lymph node through the bloodstream. 9.6 Matching: Classify each of the following activation signatures as a conventional dendritic cell (cdC) or plasmacytoid dendritic cell (pdC) pathogen response. ___1. production of CCL18 ___2. Continuous MhC recycling upon activation ___3. expression of dC-sIGn ___4. expression of Cd80 and Cd86 ___5. Cd40L expression upon TLr-9 stimulation 9.7 Short Answer: how does the process of antigen presentation differ among B cells, dendritic cells, and macrophages in the context of an immune response? 9.8 Multiple Choice: Which of the following is a common consequence of TCr and CCr7 signaling? A. Integrin activation B. positive selection C. Th1 induction D. Th2 induction 9.9 Multiple Choice: Which of the following describes a mechanism by which Cd28 signaling can increase IL-2 production?"
        },
        {
            "id": "InternalMed_Harrison_4946",
            "title": "InternalMed_Harrison",
            "content": "Molecular cytogenetics provides a link between chromosome and molecular analysis and overcomes some of the limitations of standard cytogenetics. Deletions smaller than several million base pairs are not routinely detectable by standard G-banding techniques, and chromosomal abnormalities with indistinct or novel banding patterns can be difficult or impossible to interpret. To carry out cytogenetic analysis, cells must be dividing, which is not always possible to obtain (e.g., in autopsy or tumor material that has already been fixed). Finally, growth selection or bias may occasionally cause the results of cytogenetic studies to be misleading because cells that proliferate in vitro may not be representative of the original population, as is often the case with tumor specimens."
        },
        {
            "id": "Cell_Biology_Alberts_6776",
            "title": "Cell_Biology_Alberts",
            "content": "synapses) and measure the resulting uptake of Ca2+ in the adherent T cells (Figure Q24\u20134, red circles). When you repeat the experiment in the presence of blocking antibodies against CD4, you get a different result (blue circles). Do these results support or refute the notion that CD4 augments T cell receptor binding? Explain your answer."
        }
    ],
    "scores": [
        0.026047111093840065,
        0.022116779266384213,
        0.019424799622819428,
        0.019324122479462285,
        0.019324122479462285,
        0.01899189918991899,
        0.018575851393188854,
        0.01835016835016835,
        0.018129614438063987,
        0.017050298380221655,
        0.016662057522123894,
        0.016102551149280123,
        0.015877016129032258,
        0.015584568336861915,
        0.015114143269483075,
        0.01478494623655914,
        0.014525835235526044,
        0.014399432135070729,
        0.014160133048229984,
        0.014121364736088481,
        0.013952413952413954,
        0.013542376732560781,
        0.012704686617730096,
        0.012447658926532167,
        0.01222040370976541,
        0.01210144927536232,
        0.01191151446398185,
        0.009900990099009901,
        0.009900990099009901,
        0.00980392156862745,
        0.00980392156862745,
        0.009708737864077669
    ]
}